Tag Archives: James

Cell Signaling Technology Inc.’s former Director of Intellectual Property James Cullem says that one of the highlights of his career was writing and obtaining a patent for “Immunoaffinity Isolation of Modified Peptides from Complex Mixture,” a core discovery technology that has been applied to advance biomarker and drug development. Information Nation Blog: Good morning, James Cullem and welcome. It’s a ... Read More »